129 filings
Page 3 of 7
8-K
l6n6p4udvv77ehpuw
22 Jun 22
Regulation FD Disclosure
5:28pm
8-K
ppb29b2fbq98k
8 Jun 22
Submission of Matters to a Vote of Security Holders
5:23pm
8-K
tuwt5rtem
12 May 22
Panbela Provides Business Update and Reports Q1 2022 Financial Results
4:07pm
8-K
7i95v0d
24 Mar 22
Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results
4:06pm
8-K
r6ph 423yeen9
22 Feb 22
Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
8:03am
8-K
snyndffo965w30
10 Nov 21
Panbela Provides Business Update and Reports Q3 2021 Financial Results
4:16pm
8-K
97e5gp
11 Aug 21
Panbela Provides Business Update and Reports Q2 2021 Financial Results
4:13pm
8-K
f3io nho3yyh6
2 Jul 21
Panbela Therapeutics Announces $5.0 Million Bought Deal Offering of Common Stock
4:06pm
8-K
1veio2a bmct452b
21 Jun 21
Regulation FD Disclosure
8:00am
8-K
v6j izb2iund52e23t
16 Jun 21
Regulation FD Disclosure
8:00am
8-K
fzbdvxunomlun
4 Jun 21
Regulation FD Disclosure
9:16am
8-K
sxt uyr9ol60zcgmkt
26 May 21
Panbela Announces Company Founder Dr. Michael T. Cullen to Serve as Chairman of the Board of Directors
8:03am
8-K
lbnmw7ey3x8ukeg 6qp
12 May 21
Panbela Provides Business Update and Reports Q1 2021 Financial Results
4:11pm
8-K
z5i9x2wgp8y2x 2xj
15 Apr 21
Panbela Announces Partial Clinical Hold Lifted on Phase I Polyamine Metabolic Inhibitor Study in Pancreatic Cancer
8:05am
8-K/A
r5s52f53edrjmam2il
26 Mar 21
Results of Operations and Financial Condition
8:40am
8-K
6d07b
25 Mar 21
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
12:00am
8-K
zbk95fue 1hwsu82
10 Feb 21
Regulation FD Disclosure
8:45am
8-K
otqhn17iwmw3xre sa
8 Dec 20
Regulation FD Disclosure
8:01am
8-K
77gm5mhcn xvfdeoh4hh
2 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:55pm
8-K
nbrf1nvzqz5vpxar
12 Nov 20
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results
4:11pm